Event Date: Apr 17, 2024

Recording | Related Resources

In this webinar, we are looking to achieve the following learning objectives:
  1. To appraise the role of the multiple neuropathology that is associated with dementia
  2. To understand population level estimates of risk factors and its potential reversibility
  3. To peruse current evidence for dementia prevention from RTCs
  4. To present the results from the national SYNERGIC Trial.

This integrated KTE webinar event is brought to you by brainXchange in partnership with the Alzheimer Society of Canada and the Canadian Consortium of Neurodegeneration in Aging (CCNA). 


Dr. Manuel Montero-Odasso, MD, PhD, FRCPC, AGSF, FGSA, FCAHS
Dr. Manuel Montero-Odasso is trained as an internist, geriatrician and clinician-scientist. He is currently Professor and Faculty Scholar at the Departments of Medicine (Geriatric Medicine) and Epidemiology and Biostatistics, at the University of Western Ontario and Director of the Gait & Brain Lab at the Parkwood Institute in London, where his research focuses on how cognitive and motor decline interact with aging and neurodegeneration and predict dementia, falls and frailty.

As team leader of the Canadian Consortium on Neurodegeneration in Aging (CCNA), he is co-Principal Investigator in the Canadian Therapeutic Platform for Multi-domain Interventions to Prevent Dementia (CAN-Thumbs-UP); he leads clinical trials (SYNERGIC Trial), to delay dementia in older adults with Mild Cognitive Impairment, by using personalized medicine and multi-domain lifestyle interventions and also leads the CCNA Training & Capacity Building Program, a national platform that fosters a training environment for CCNA members and trainees with the goal of building the next generation of researchers working on brain health and cognitive impairment in aging.  

Dr. Montero-Odasso serves as President of the Canadian Geriatrics Society, and was inducted as one of the 2019 Top 10 Hispanic Canadian for his contribution in Medicine and Science.